Video Notes: Endocrine Medications and Insulin Management (60 VOCAB Cards)

Medication Therapy for Adrenal Disorders

• Key medications and their uses
  • Hydrocortisone
  • A glucocorticoid
  • Treats acute and chronic adrenocortical insufficiency
  • Also used in Addison disease as a primary glucocorticoid therapy
  • Fludrocortisone
  • A mineralocorticoid
  • Used to provide mineralocorticoid replacement (often in Addison disease)
  • Somatropin
  • Growth hormone
  • Treats growth hormone deficiencies
  • Example: Turner's syndrome (growth hormone deficiency associated with Turner's)
  • Addison disease
  • Adrenal insufficiency requiring glucocorticoid and often mineralocorticoid replacement
  • Turner's syndrome
  • A chromosomal condition associated with short stature and growth hormone deficiency; treated with Somatropin
  • Propylthiouracil (PTU)
  • Antithyroid medication
  • Treats hyperthyroidism or Graves’ disease and thyrotoxic crisis
  • Levothyroxine
  • Thyroid replacement hormone (synthetic T4)
  • Treats hypothyroidism
• Medication Information Table (relationships observed in transcript)
  • Fludrocortisone → Addison disease (mineralocorticoid replacement in adrenal insufficiency)
  • Somatropin → Turner's syndrome (growth hormone deficiency in Turner's syndrome)
  • Hydrocortisone → Addison disease (glucocorticoid replacement in adrenal insufficiency)
  • Propylthiouracil → Thyrotoxic crisis / hyperthyroidism (antithyroid therapy)
  • Levothyroxine → Hypothyroidism (thyroid hormone replacement)
  • Turner's syndrome → Somatropin (growth hormone therapy)
• Concepts and clinical significance
  • Addison disease management requires replacement of both glucocorticoids and mineralocorticoids; hydrocortisone provides glucocorticoid activity and partial mineralocorticoid activity, while fludrocortisone provides mineralocorticoid activity
  • Turner's syndrome commonly involves growth hormone deficiency; Somatropin is used to promote growth
  • Hyperthyroidism management includes antithyroid drugs like Propylthiouracil; thyrotoxic crisis is a severe, acute form of thyrotoxicosis requiring rapid management
  • Hypothyroidism is treated with thyroid hormone replacement (Levothyroxine)
• Insulin self-injection teaching (nurse-guided patient education from transcript)
  • Patient scenario
  • The client will self-inject eight units of NPH insulin and four units of regular insulin each day before breakfast
  • Dosing: $8\text{ units (NPH)}$ and $4\text{ units (regular)}$ before breakfast
  • Correct preparation and administration steps
  • Draw the regular insulin into the syringe first, then the NPH insulin
    • Rationale: clear insulin (regular) first, then cloudy insulin (NPH), to avoid contaminating the regular insulin vial with NPH
  • Do not inject the insulin mixture into a large muscle
    • Route: subcutaneous injection, not intramuscular
  • Do not discard unused premixed syringes within 5 days
    • Premixed syringes can be stored refrigerated for about 1 week; keep refrigerated and stored vertically with needles pointing upward
  • Use a 5-mL syringe when mixing two types of insulin
    • Note on actual practice: insulin syringes are typically used for U-100 insulin; the transcript lists a 5-mL syringe option, but standard practice uses insulin syringes sized appropriately for units of insulin
  • Use one syringe to reduce the number of injections
    • If appropriate, mixing insulins in the same syringe reduces injections
  • The client may mix NPH insulin and regular insulin in the same syringe to reduce the number of injections
    • Allowed practice for mixing regular (short-acting) and NPH (intermediate-acting) insulins in one syringe
  • The client should not mix glargine or insulin detemir with any other insulin
    • Long-acting insulins (glargine, detemir) should not be mixed with other insulins
  • Additional practical notes from the transcript
  • Accuracy and dosing safety: always use an insulin syringe to prevent dosing errors
  • Storage and handling: premixed syringes can be stored in the refrigerator for follow-up doses; gently resuspend before injection
• Practical implications and safety considerations
  • Correct sequence and site of injection are critical to ensure predictable onset and duration of action
  • Mixing insulins can reduce injections but requires precise technique to avoid altered pharmacokinetics (e.g., onset of regular insulin if mixed improperly with NPH or other types)
  • Long-acting insulins (glargine, detemir) should not be mixed with other insulins to maintain their steady-state action
  • Patient education should emphasize rotating injection sites, recognizing signs of hypo-/hyperglycemia, and proper storage of premixed syringes
• Connections to foundational principles and real-world relevance
  • Endocrine pharmacology basics: receptor types, hormone replacement vs antagonist therapy, and organ-specific hormone targets
  • Clinical decision-making: tailoring therapy to deficiency type (glucocorticoid vs mineralocorticoid vs growth hormone vs thyroid hormone) and to patient-specific conditions (Addison disease, Turner's syndrome, hypothyroidism, hyperthyroidism)
  • Safety and ethics: ensuring safe dosing, minimizing injections when possible, and avoiding unsafe practices (e.g., mixing long-acting insulins with others)
• Key formulas and numerical references (LaTeX)
  • Insulin dosing example from transcript: $8\ \text{units of NPH} + 4\ \text{units of regular insulin}$ per day before breakfast
  • Storage guidance (time frame) in practice: premixed syringes stored for about $1\ \text{week}$ refrigerated; upright with needles pointing upward
• Summary of takeaways
  • Hydrocortisone and fludrocortisone are used to treat Addison disease (glucocorticoid and mineralocorticoid replacement, respectively)
  • Somatropin is used for growth hormone deficiencies, notably Turner's syndrome
  • Propylthiouracil treats hyperthyroidism and thyrotoxic crisis; Levothyroxine treats hypothyroidism
  • In insulin management, draw regular insulin first when mixing with NPH, administer subcutaneously, and consider mixing to reduce injections while avoiding mixing long-acting insulins with others; store premixed syringes properly and resuspend gently before use